openPR Logo
Press release

Tetanus Toxoid Vaccine Market Projected to Reach $ 5.5 billion at 5.3% CAGR Till 2023 | Global Key Players – GlaxoSmithKline Plc., Merck & Co. Inc., Pfizer, Inc., Sanofi Pasteur, Inc., AstraZeneca Plc., Bharat Biotech.

08-20-2018 11:33 AM CET | Health & Medicine

Press release from: Market Research Future

Tetanus Toxoid Vaccine Market Projected to Reach $ 5.5 billion

Market Research Future has announced the addition of the "Global Tetanus Toxoid Vaccine Market Research Report which gives Market Size, Shares and Forecasts till 2023. The Tetanus Toxoid Vaccine Industry Report Provide analysis and evaluation of the current and prospective profitability.

Global Tetanus Toxoid Vaccine Market -Scenario

Tetanus is an infectious disease caused by Clostridium tetani characterized by muscle spasms. The spasms may be very severe and even cause bone fractures. Other symptoms include fever, sweating, headache, trouble swallowing, hypertension etc. About 10% of those infected, die while a large number become incapacitated due to bone fractures.

Request Sample with New Technological Trends @ https://www.marketresearchfuture.com/sample_request/4024

Tetanus toxoid vaccine is an inactive vaccine used to prevent tetanus by developing immunity against the pathogen causing tetanus. The general dosage recommendation is five doses during childhood, with a sixth given during adolescence with additional doses every 10 years.

The tetanus vaccine was initially developed in 1924 and has resulted in a 95% decrease in the rate of tetanus in the US and is on the World Health Organization's List of Essential Medicines. The vaccine also is considered very safe even during pregnancy and for those with HIV.

Global Tetanus Toxoid Vaccine Market -Key players

Key players profiled in the report are

GlaxoSmithKline Plc.,
Merck & Co. Inc.,
Pfizer, Inc.,
Sanofi Pasteur, Inc.,
AstraZeneca Plc.,
Bharat Biotech,
Shenzhen Kangtai Biological Products,
Valeant Pharmaceuticals,
Emergent Biosolutions Inc.,
Astellas Pharma Inc.,
Panacea Biotec

Considering all these factors, the market for Tetanus toxoid vaccine is expected to reach $ 5.5 billion by the end of 2023, this market is projected to growing at a CAGR of ~ 5.3 % during 2017-2023.

Global Tetanus Toxoid Vaccine Market -Segments

The global tetanus toxoid vaccine market is segmented on the basis of types, forms and end users. Based on types, the market has been segmented as monovalent tetanus toxoid (TT), diphtheria, tetanus, and pertussis (DTaP), diphtheria and tetanus (DT), tetanus, diphtheria, and pertussis (Tdap) and others.

Based on the forms, the market has been segmented as quadrivalent, pentavalent, and hexavalent. Based on the end users, the market has been segmented as biotech and hospitals and clinics, government organizations, research and others.

Access Report Details with TOC @ https://www.marketresearchfuture.com/reports/tetanus-toxoid-vaccine-market-4024

Global Tetanus Toxoid Vaccine Market -Regional analysis

US accounts for the maximum market share due to greater use of medications and greater expenditure on healthcare. The faster market uptake of new technology and devices in the US is also an important driver of the market for global Tetanus toxoid vaccine. Europe is the second largest market due to large disposable income and rising awareness.

Asia Pacific region is expected to have the most future potential and it is estimated to be led by China and India. The Middle East & Africa market is led by the gulf nations particularly Saudi Arabia and UAE. The regions of Africa are expected to witness a moderate growth due to poor economic and political conditions and poor healthcare penetration.

Global Tetanus Toxoid Vaccine -Major Points from TOC

Chapter 1. Report Prologue

Chapter 2. Market Introduction

Chapter 3. Research Methodology

Chapter 4. Market Dynamics

Chapter 5. Market Factor Analysis

Chapter 6. Global Tetanus Toxoid Vaccine Market, By Type

Chapter 7. Global Tetanus Toxoid Vaccine Market, By Treatment

Chapter 8 Global Tetanus Toxoid Vaccine Market, By End User

Chapter 9. Global Tetanus Toxoid Vaccine Market, By Region

Chapter 10 Company Landscape

Chapter 11 Company Profiles

Chapter 12 MRFR Conclusion

Chapter 13 Appendix

Avail Attractive Discount @ https://www.marketresearchfuture.com/check-discount/4024

About US:

Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

Phone: +1 646 845 9312

Email: sales@marketresearchfuture.com

Contact Us:

Market Research Future

Office No. 528, Amanora Chambers

Magarpatta Road, Hadapsar,

Pune - 411028

Maharashtra, India

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Tetanus Toxoid Vaccine Market Projected to Reach $ 5.5 billion at 5.3% CAGR Till 2023 | Global Key Players – GlaxoSmithKline Plc., Merck & Co. Inc., Pfizer, Inc., Sanofi Pasteur, Inc., AstraZeneca Plc., Bharat Biotech. here

News-ID: 1187961 • Views:

More Releases from Market Research Future

9-Decanoic Acid Methyl Ester Market Poised for Strong 6.59% CAGR Growth Through 2035
9-Decanoic Acid Methyl Ester Market Poised for Strong 6.59% CAGR Growth Through …
The 9-decanoic acid methyl ester market is a growing sector driven by the increasing demand for bio-based and sustainable chemical products across various industries. With its unique properties, it finds application in flavors and fragrances, pharmaceuticals, personal care, and as a chemical intermediate. The market is projected to expand significantly in the coming years. Market Overview and Size The global 9-decanoic acid methyl ester market was valued at USD 230.0 million in
Washable Marker Market Poised for 3.54% CAGR Growth During 2024-2032
Washable Marker Market Poised for 3.54% CAGR Growth During 2024-2032
The washable marker market is a dynamic and growing segment within the broader stationery and art supplies industry. Driven by a blend of consumer demands for safety, convenience, and sustainability, the market is experiencing consistent expansion, particularly within the education and home-use sectors. While faced with some challenges, the industry's future looks promising, propelled by product innovation and evolving consumer trends. Get Sample @ https://www.marketresearchfuture.com/sample_request/41217 Market Size and Growth The global washable
Phone Car Mounts Market to Reach USD 7.37 Billion by 2034, Growing at 6.47% CAGR
Phone Car Mounts Market to Reach USD 7.37 Billion by 2034, Growing at 6.47% CAGR
The phone car mounts market, a critical sub-segment of the broader automotive accessories industry, is experiencing robust growth driven by a convergence of technological advancements, evolving consumer behavior, and increasingly stringent road safety regulations. As smartphones become indispensable for navigation, communication, and in-car entertainment, the demand for secure and convenient hands-free solutions continues to escalate. The global phone car mounts market was valued at USD 3.93 billion in 2024 and
Intravenous (IV) Solution Market Set to Grow to USD 26.60 Billion at 7.70% CAGR by 2032
Intravenous (IV) Solution Market Set to Grow to USD 26.60 Billion at 7.70% CAGR …
Market Overview: The Intravenous (IV) Solution Market is estimated to be valued at USD 13.9 billion in 2023 and is projected to reach USD 26.60 billion by 2032, expanding at a compound annual growth rate (CAGR) of 7.70% from 2024 to 2031. The market growth is attributed to the rising prevalence of chronic diseases, growing hospitalization rates, and increasing surgical procedures that require IV fluid administration. Intravenous solutions are critical

All 5 Releases


More Releases for Tetanus

Tetanus Market Value Projected to Expand by 2029
Tetanus Market size was valued at USD billion in 2023 and is expected to grow at a compound annual growth rate (CAGR) of 21.36% from 2024 to 2030. Welcome to our comprehensive exploration of the Tetanus market, where we uncover the trends, innovations, and dynamics shaping the landscape of tetanus prevention and treatment. Tetanus, a potentially life-threatening bacterial infection, continues to pose challenges globally, driving the demand for effective preventive
Diphtheria, Pertussis, and Tetanus Vaccine Market
According to a new report published by Allied Market Research, titled, "Diphtheria, Pertussis, and Tetanus Vaccine Market by Product Type [DTaP (Daptacel, Infanrix, Kinrix, Pediarix, Pentacel, and Quaracel), Td (Decavac and Tenivac), and Tdap (Boostrix and Adacel)], Vaccine Type (Whole-Cell Vaccine and Acellular Vaccine), Age Group (Adult and Pediatric), and End User (Hospitals, Clinics, and Vaccination Centers) - Global Opportunity and Forecast, 2019-2026 ". The Global market size of Diphtheria, Pertussis,
Tetanus Therapeutics- Pipeline Analysis 2018 | Zydus Group
Tetanus, also known as lockjaw is a bacterial disease caused by Clostridium tetani. The bacteria are usually found in dust, soil, and manure and enter the body through breaks in the skin. The spores develop into bacteria when they enter the body. Download the sample report @ https://www.pharmaproff.com/request-sample/1074 These spores can get into the body through broken skin, usually through injuries from contaminated objects. Certain breaks in the skin are more
Tetanus-Pipeline Review H2 2018
Tetanus (Infectious Disease) pipeline guide helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage. The guide is built using data and information sourced from Publisher's proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources. Additionally, various
Tetanus-Pipeline Review H2 2018
Tetanus (Infectious Disease) pipeline guide helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage. The guide is built using data and information sourced from Publisher's proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources. Additionally, various
Tetanus - Pipeline Review, H1 2017
ReportsWorldwide has announced the addition of a new report title Tetanus - Pipeline Review, H1 2017 to its growing collection of premium market research reports. Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Tetanus - Pipeline Review, H1 2017, provides an overview of the Tetanus (Infectious Disease) pipeline landscape. Tetanus is a serious illness caused by Clostridium bacteria. Signs and symptoms of tetanus include spasms and stiffness in jaw muscles,